Given the contribution of the enhanced glucuronate pathway and TGFβ signalling to hepatoma cell migration upon GSTZ1 knockout, we determined whether blockage of the glucuronate pathway or TGFβ signalling dampens Gstz1‐deletion dependent tumour promotion. The gene discussed is GSTZ1; the disease is neoplasm.